Fatal Overdose Reveals How Venlafaxine and Mirtazapine Spread Through the Body After Death

A fatal case involving two commonly prescribed antidepressants has given forensic toxicologists an unusually detailed map of where these drugs accumulate in the body after death. In a report published in the International Journal of Legal Medicine, researchers describe the death of a 33-year-old man with schizoaffective disorder who was found dead at home beside empty venlafaxine blister packs. Toxicological analysis identified venlafaxine, its metabolite O-desmethylvenlafaxine, mirtazapine, its metabolite N-desmethylmirtazapine, and the benzodiazepines delorazepam and lorazepam across multiple biological matrices, including central blood, peripheral blood, urine, brain and liver.

The analytical work relied on systematic toxicological screening by liquid chromatography coupled to tandem mass spectrometry and full-scan gas chromatography–mass spectrometry. Once the compounds were identified, the team quantified them in each matrix using a validated LC–MS/MS method. Intact venlafaxine tablets were also recovered from the gastric and duodenal content.

The peripheral blood concentrations stood out. Venlafaxine measured 4.42 milligrams per litre and mirtazapine 0.72 milligrams per litre. Both values exceeded the therapeutic ranges for these drugs, yet both remained below the lowest concentrations reported in any published fatal case involving either drug on its own. That pattern led the authors to point to an additive, and likely synergistic, toxic interaction between the two compounds rather than a lethal overdose of a single agent.

By contrast, delorazepam and lorazepam were present only at therapeutic concentrations. The investigators attributed the cause of death to acute combined venlafaxine–mirtazapine overdose and classified the manner of death as suicide.

According to the authors, this is the first reported fatal venlafaxine–mirtazapine co-ingestion with multi-matrix postmortem quantification. Only a handful of previous cases have documented venlafaxine concentrations in brain tissue after a fatal overdose, which makes the brain measurements in this case particularly valuable for the forensic community.

Postmortem redistribution is a central challenge in interpreting drug levels measured after death. Drug concentrations can differ markedly between central blood drawn from the heart and peripheral blood drawn from a limb, because drugs stored in organs such as the liver and lungs can diffuse back into central blood as the body’s circulation stops. Comparing central and peripheral blood, alongside solid organs like brain and liver, helps toxicologists judge whether a measured concentration reflects what circulated in life or an artifact of the postmortem interval.

The multi-matrix approach in this case illustrates why that comparison matters. Venlafaxine and mirtazapine act on different neurotransmitter systems: venlafaxine inhibits the reuptake of serotonin and norepinephrine, while mirtazapine blocks certain serotonin and alpha-2 receptors. When two agents with distinct but overlapping serotonergic activity are taken together, their combined effect on serotonin signalling can exceed what either drug alone would produce at the same blood level. This pharmacodynamic interaction offers a plausible explanation for why blood concentrations below single-drug fatal thresholds could still be lethal in combination.

For death investigators, the case underscores the importance of quantifying drugs not only in blood but in urine, brain and liver tissue, where metabolite patterns and concentration gradients can clarify the timing and scale of ingestion. The presence of intact tablets in the gastric and duodenal content, together with elevated parent drug and metabolite levels across matrices, supported the conclusion that a large recent overdose had occurred.

By documenting venlafaxine and mirtazapine levels simultaneously in five biological matrices, the case adds reference data that forensic pathologists and toxicologists can draw on when they encounter similar combined overdoses. As antidepressant co-ingestions continue to appear in medicolegal casework, such detailed distribution studies help distinguish therapeutic use, accumulation and fatal interaction in the interpretation of postmortem findings.

Subject of Research: Postmortem distribution of venlafaxine and mirtazapine in a fatal combined overdose

Article Title: Multi-matrix postmortem distribution in fatal venlafaxine–mirtazapine intoxication

Article References: Camatti, J., Verri, P., Palazzoli, F., Vandelli, D., Castagnetti, V., Cecchi, R., & Santunione, A. L. (2026). Multi-matrix postmortem distribution in fatal venlafaxine–mirtazapine intoxication. International Journal of Legal Medicine. https://doi.org/10.1007/s00414-026-04043-1

Image Credits: AI Generated

DOI: 10.1007/s00414-026-04043-1

Keywords: forensic toxicology, venlafaxine, mirtazapine, postmortem redistribution, LC-MS/MS, drug interaction, antidepressant overdose, suicide, blood concentration, brain tissue, case report, Multi-matrix